Oncorus Inc. Gains 669.23%

Wed, Dec 27, 2023 at 11:30 PM

Oncorus Inc. (ONCR:NASDAQ) soared at $0.1, a gain of 669.2%. On Wed, Dec 27, 2023, ONCR:NASDAQ touched a New 2-Week High of $0.1. From Thu, Dec 14, 2023, the stock recorded 12.50% Up Days and 11.11% Green Days

About Oncorus Inc. (ONCR:NASDAQ)

Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients.

Top 10 Gainers:

Oncorus Inc. (ONCR:NASDAQ), 669.23%
Esports Technologies Inc. (EBET:NASDAQ), 244.43%
RiskOn International Inc Com Par $0.001 (ROI:NASDAQ), 205.4%
Republic First Bancorp, Inc. (FRBK:NASDAQ), 110.74%
Cingulate Inc. (CING:NASDAQ), 90.91%
Cytokinetics, Incorporated (CYTK:NASDAQ), 82.54%
Earlyworks Co. Ltd. (ELWS:NASDAQ), 69.31%
Erayak Power Solution Group Inc. (RAYA:NASDAQ), 50.73%
First Wave BioPharma Inc. (FWBI:NASDAQ), 50.27%
Vince Holding Corp. (VNCE:NYSE), 48.68%